NASDAQ:CALC CalciMedica (CALC) Stock Price, News & Analysis $1.17 -0.05 (-4.10%) Closing price 04:00 PM EasternExtended Trading$1.16 -0.01 (-0.85%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About CalciMedica Stock (NASDAQ:CALC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CalciMedica alerts:Sign Up Key Stats Today's Range$1.15▼$1.2250-Day Range$1.02▼$2.3052-Week Range$1.00▼$36.00Volume33,644 shsAverage Volume172,136 shsMarket Capitalization$8.07 millionP/E RatioN/ADividend YieldN/APrice Target$50.00Consensus RatingHold Company Overview CalciMedica is a clinical-stage biopharmaceutical company developing treatments for serious inflammatory and immunologic conditions. Its research focuses on calcium release-activated calcium (CRAC) channels, which play a role in immune-cell activity and inflammation. The company’s lead drug candidate, Auxora, is an investigational CRAC channel inhibitor being studied for acute inflammatory conditions, including acute pancreatitis. CalciMedica has no marketed products; its candidates remain in clinical development. Based in La Jolla, California, CalciMedica became a publicly traded company in 2024 through a business combination with Orion Acquisition Corp. The company’s work is centered on developing and testing its therapies, rather than commercial product sales.AI Generated. May Contain Errors. Read More CalciMedica Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks53rd Percentile Overall ScoreCALC MarketRank™: 2.663775850565 of 5 starsCalciMedica scored higher than 53% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingHold Consensus RatingCalciMedica has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on no strong buy ratings, 2 buy ratings, 2 hold ratings, and 1 sell rating.Upside PotentialCalciMedica has a consensus price target of $50.00, representing about 4,173.5% upside from its current price of $1.17.Amount of Analyst CoverageCalciMedica has only been the subject of 2 research reports in the past 90 days.Read more about CalciMedica's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for CalciMedica are expected to grow in the coming year, from ($1.93) to ($1.61) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CalciMedica is -0.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of CalciMedica is -0.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCalciMedica has a P/B Ratio of 1.92. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.50% of the float of CalciMedica has been sold short.Short Interest Ratio / Days to CoverCalciMedica has a short interest ratio ("days to cover") of 1.78, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CalciMedica has recently increased by 178.04%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCalciMedica does not currently pay a dividend.Dividend GrowthCalciMedica does not have a long track record of dividend growth. News and Social Media3.0 / 5News Sentiment0.74 News SentimentCalciMedica has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for CalciMedica this week, compared to 2 articles on an average week.Search InterestOnly 4 people have searched for CALC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, CalciMedica insiders have not sold or bought any company stock.Percentage Held by Insiders28.25% of the stock of CalciMedica is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsCalciMedica has minimal institutional ownership at this time.Read more about CalciMedica's insider trading history. Receive CALC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CalciMedica and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CALC Stock News HeadlinesFY2026 EPS Estimates for CalciMedica Raised by HC WainwrightNovember 14, 2026 | americanbankingnews.comCalciMedica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 11, 2026 | marketscreener.comMELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th. A free Masterclass claims to reveal what Musk filed with regulators and why he's working to keep it quiet.November 18 at 1:00 AM | Paradigm Press (Ad)CalciMedica Reports Third Quarter 2026 Financial Results and Provides Clinical & Corporate UpdatesNovember 10, 2026 | globenewswire.comCalciMedica (CALC) Set to Release Earnings on WednesdayNovember 10, 2026 | americanbankingnews.comCalciMedica to Participate in the Guggenheim 3rd Annual Healthcare Innovation ConferenceNovember 3, 2026 | globenewswire.comCalciMedica (CALC) Stock Forecast & Price TargetOctober 21, 2026 | investing.comCalciMedica consensus price target raised 400% to $38.25September 15, 2026 | msn.comSee More Headlines CALC Stock Analysis - Frequently Asked Questions How have CALC shares performed this year? CalciMedica's stock was trading at $32.95 at the beginning of 2026. Since then, CALC shares have decreased by 96.4% and is now trading at $1.17. How were CalciMedica's earnings last quarter? CalciMedica Inc. (NASDAQ:CALC) announced its quarterly earnings results on Tuesday, November, 10th. The company reported ($0.24) EPS for the quarter, beating analysts' consensus estimates of ($1.27) by $1.03. When did CalciMedica's stock split? CalciMedica's stock reverse split on Monday, August 31st 2026.A 1-5 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, August 30th 2026. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split. When did CalciMedica IPO? CalciMedica (CALC) raised $90 million in an initial public offering on Friday, September 25th 2020. The company issued 5,625,000 shares at $15.00-$17.00 per share. How do I buy shares of CalciMedica? Shares of CALC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/10/2026Today11/18/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 CALC's financial health is in the Yellow zone, according to TradeSmith. CALC has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:CALC CIK1534133 Webwww.calcimedica.com Phone858-952-5500FaxN/AEmployees12Year Founded2007Price Target and Rating Average Price Target for CalciMedica$50.00 High Price Target$50.00 Low Price Target$50.00 Potential Upside/Downside+4,173.5%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($4.44) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$29.56 million Net MarginsN/A Pretax MarginN/A Return on Equity-4,239.00% Return on Assets-151.02% Debt Debt-to-Equity Ratio1.63 Current Ratio4.96 Quick Ratio4.96 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.61 per share Price / Book1.92Miscellaneous Outstanding Shares6,900,000Free Float4,947,000Market Cap$8.07 million OptionableNo Data Beta0.84 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:CALC) was last updated on 11/18/2026 by MarketBeat.com Staff. From Our PartnersPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CalciMedica Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CalciMedica With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.